Literature DB >> 22014765

Visceral fat volume predicts new-onset type 2 diabetes in patients with chronic hepatitis C.

Motoh Iwasa1, Rumi Mifuji-Moroka, Nagisa Hara, Masumi Ishidome, Kazuko Iwata, Ryosuke Sugimoto, Hideaki Tanaka, Naoki Fujita, Yoshinao Kobayashi, Yoshiyuki Takei.   

Abstract

Ninety seven patients with chronic hepatitis C (CHC) and 72 with non-alcoholic fatty liver disease (NAFLD) were enrolled. Increased visceral fat area (VFA) was associated with high values of HbA1c. The variables associated with a high risk of new-onset diabetes had a VFA>101 cm(2) in CHC, but not in NAFLD.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22014765     DOI: 10.1016/j.diabres.2011.09.016

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  4 in total

Review 1.  MRI adipose tissue and muscle composition analysis-a review of automation techniques.

Authors:  Magnus Borga
Journal:  Br J Radiol       Date:  2018-07-24       Impact factor: 3.039

2.  Body Composition Profiling in the UK Biobank Imaging Study.

Authors:  Jennifer Linge; Magnus Borga; Janne West; Theresa Tuthill; Melissa R Miller; Alexandra Dumitriu; E Louise Thomas; Thobias Romu; Patrik Tunón; Jimmy D Bell; Olof Dahlqvist Leinhard
Journal:  Obesity (Silver Spring)       Date:  2018-05-22       Impact factor: 5.002

3.  Visceral fat area is associated with HbA1c but not dialysate-related glucose load in nondiabetic PD patients.

Authors:  Li-chun Ho; Chung-Jen Yen; Chia-Ter Chao; Chih-Kang Chiang; Jenq-Wen Huang; Kuan-Yu Hung
Journal:  Sci Rep       Date:  2015-08-04       Impact factor: 4.379

Review 4.  Advanced body composition assessment: from body mass index to body composition profiling.

Authors:  Magnus Borga; Janne West; Jimmy D Bell; Nicholas C Harvey; Thobias Romu; Steven B Heymsfield; Olof Dahlqvist Leinhard
Journal:  J Investig Med       Date:  2018-03-25       Impact factor: 2.895

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.